terest from a quality improvement perspective is whether practice patterns tend to vary widely even among urologists in the same practice and/or based on her or his panel size (ie, the volume of men with low-risk prostate cancer a given urologist manages). In the context of limited resources, the availability of such information may be used to develop efficient improvement interventions aimed at optimizing the implementation of AS among diverse urologists and practice settings.
Methods | The Michigan Urological Surgery Improvement
Collaborative is a consortium of 43 academic and community urology practices in Michigan that maintains a prospective clinical registry with detailed and validated clinical information for men newly diagnosed as having prostate cancer seen in participating practices. For this analysis, we identified all Michigan Urological Surgery Improvement Collaborative practices with at least 5 urologists who each managed 5 or more men with low-risk prostate cancer from January 2012 through July 2016. We then examined the proportion of men managed primarily with AS across practices and among urologists within each practice, adjusting for differences in patient age and comorbidity. Finally, we fit a linear regression model to estimate the association between the proportion of patients entering AS and urologist panel size. Two-sided testing was performed, with P < .05 considered significant (StataCorp).
Each practice obtained institutional review board approval of not-regulated or exempt status or had an expedited review for collaborative participation. As a part of the institutional review board process at all participating sites, it was determined that given the quality improvement focus of the Michigan Urological Surgery Improvement Collaborative and the fact that the data it houses are (1) collected for quality improvement and not human participants research and (2) is collected during routine care of patients (eg, does not require any changes or burdens beyond routine care processes), informed consent was not necessary.
Results | We identified 124 urologists from 13 practices who managed 2643 men (median age, 64 years) diagnosed as having low-risk prostate cancer during the interval of interest. The Practice, No.
Median patient age was 64 years; median prostate-specific antigen level was 5.0 ng/mL; and Charlson comorbidity score was 0 for 1868 men, 1 for 415 men, and 2 or higher for 360 men. Adjusted AS rates for each urologist and practice were estimated using a multivariable logistic regression model fit to account for differences in patient age and comorbidity among urologists. In the model, age was a continuous predictor, and Charlson comorbidity was a categorical predictor (categories = 0, 1, and Ն2). We defined low-risk according to criteria from the National Comprehensive Cancer Network (ie, clinical stage ՅT2a, prostate-specific antigen <10 ng/mL, and biopsy Gleason score Յ6). 6 The number of urologists per practice varies from 5 to 38. The size of each dot is scaled to represent individual clinician panel size (range, 5-141) . median practice and urologist panel size was 165 patients (range, 70-524) and 16 patients (range, 5-141), respectively. The adjusted proportion of men entering initial AS varied significantly across practices (median, 57.3%; range, 30.2%-72.6%; P < .001) (Figure 1 ). In almost all practices, urologist-specific use of AS also varied widely; in 1 practice, for instance, the adjusted rates varied from 0% to 95.6% among more than 30 urologists ( Figure 1 ). We identified no significant association between a urologist's panel size and rates of AS use (R 2 = 0.02; P = .17) ( Figure 2 ).
Discussion | The use of AS for primary management of men with low-risk prostate cancer varies widely both across and within urology practices in Michigan; moreover, the propensity to use AS does not appear to correlate with a urologist's low-risk prostate cancer panel size. Although our analysis is limited by small sample size for some urologists and a lack of insight on patient preferences, our findings nonetheless provide evidence that individual urologists develop treatment patterns for men with low-risk prostate cancer that differ markedly from both others in the same group practice and from colleagues with similar experience managing men with prostate cancer. Collectively, these data indicate that quality improvement activities focused only on specific practices or on urologists who see a high or low volume of patients with prostate cancer may be less effective at addressing variation in use of AS. Instead, such activities should be tailored to individual physicians. In Michigan, these findings are guiding our interventions to improve AS including dissemination of a clinical roadmap for men with favorable-risk prostate cancer that aims to achieve more consistent practice patterns as urologists consider the appropriateness 5 and implementation of AS. The roadmap is being delivered via personalized outreach that also includes clinician-level performance measures that allow individuals to understand their own practice relative to patterns of care for other urologists within their group and across Michigan. 
Association of Procedures and Patient Factors With 30-Day Readmission Rates After Pediatric Surgery
Efforts to create verified pediatric surgical centers require rigorous standards to ensure quality across surgical specialties. However, risk factors for readmission after pediatric surgery are poorly understood. This study aims to identify surgical procedures and patient factors associated with increased rates of readmission from the American College of Surgeons Pediatric National Surgical Quality Improvement Program (NSQIP-P) database.
Methods | A retrospective review of data from the American College of Surgeons NSQIP-P Participant Use Data File from 2012 to 2014 was performed. The NSQIP-P collects data on 147 variables, including preoperative risk factors and intraoperative variables, and tracks 30-day outcomes. 1 The data include children younger than 18 years at 56 children's hospitals in the United States. This research was deemed exempt by the University of California, Davis institutional review board, which waived the need for patient consent because this was an analysis of a national, deidentified database. We examined all readmissions within 30 days, both related and unrelated to the index operation. Procedures with the highest unplanned readmission rates were identified. Unplanned readmission rates were calculated by specialty. A multivariable logistic regression identified factors predicting unplanned readmission. The analysis of unplanned readmissions is limited to operations with case volumes of at least 39 patients (corresponding to the 25th percentile) to avoid skewing data toward rarely performed procedures. Analysis was performed in Stata, version 14.1 (StataCorp). Significance was defined as P <.05 (1-sided).
Results | Of 183 233 patients captured by NSQIP-P from 2012 to 2014, 8838 patients (4.8%) were readmitted within 30 days, and 712 patients (8.1% of readmitted patients) had more than 1 readmission within 30 days. Almost half of readmissions (n = 4256; 47.0%) were unrelated to the index operation.
Most readmissions (84.3%) were unplanned. Operations with the highest overall unplanned readmission rates were laparoscopic ileostomy/jejunostomy, portoenterostomy, and diagnostic thoracoscopy (Table 1) . By specialty, unplanned readmission rates were highest among neurosurgical operations (n = 1598; 11.2%) compared with other specialties (n = 6-3630; 1.3%-5.4%). The median time to readmission (within 30 days) was 13 days (25th percentile, 8 days; 75th percentile, 21 days).
The most common reason for related readmissions was surgical site infection including superficial and deep incisional surgical site infection, organ/space surgical site infection, and wound disruption (n = 1374; 29.4%). The next most common reason was urinary tract infection (n = 174; 3.7%). Of patients with surgical site infections, the most common index procedures were laparoscopic appendectomy, posterior arthrodesis, craniectomy, and operations related to ventriculoperitoneal shunts. The most common reasons for unrelated readmissions were seizure (n = 30; 1.7%), pneumonia (n = 29; 1.6%), and urinary tract infection (n = 24; 1.3%).
On multivariable logistic regression, predictors of 30-day unplanned readmission included patients undergoing neurosurgical procedures (vs pediatric general surgery: odds ratio [OR], 2.52; 95% CI, 1.96-3.23; P < .001), female sex (OR, 1.24; 95% CI, 1.06-1.44; P = .008), Asian race/ethnicity (vs white: OR, 1.64; 95% CI, 1.10-2.44; P = .02), higher American Society of Anesthesiologists classification (American Society of Anesthesiologists class 2-4 vs 1: class 2 OR, 2.01; 95% CI, 1.47-2.75; class 2 OR, 3.68; 95% CI, 2.66-5.09; class 4 OR, 2.92; 95% CI, 1.98-4.32; P < .001), current cancer or active cancer treatment (OR, 2.06; 95% CI, 1.24-3.42; P = .005), patients with cerebral palsy (OR, 3.69; 95% CI, 1.77-7.69; P < .001), patients with clean-contaminated cases (OR, 1.28; 95% CI, 1.05-1.56; P = .01), and laparoscopic procedures (OR, 1.55; 95% CI, 1.28-1.87; P < .001; Table 2 ). Patients had lower odds of unplanned readmission if they underwent urologic procedures (vs pediatric general surgery: OR, 0.70; 95% CI, 0.50-0.98; P = .04) or 
